Keyphrases
Prostaglandins
100%
Rat Mesenteric Artery
100%
EP2 Receptor
100%
Vasorelaxation
100%
14,15-epoxyeicosatrienoic Acid
100%
Receptor Antagonist
45%
Peroxisome Proliferator-activated Receptor
36%
Acid Activation
27%
Prostaglandin E2
18%
Cell Membrane
18%
G Protein
18%
Vasodilator
18%
Prostanoid Receptors
18%
PKA Pathway
18%
Epoxyeicosatrienoic Acids
18%
Proteinase Inhibitor
9%
Indomethacin
9%
Small Interfering RNA (siRNA)
9%
Relaxation Effect
9%
Vascular Smooth muscle Cells
9%
Binding Studies
9%
Protein-coupled Receptor
9%
KT5720
9%
GW9662
9%
Arterial Smooth muscle
9%
Cyclooxygenase Inhibitors
9%
MK886
9%
Nuclear Membrane
9%
EP2 Receptor Agonist
9%
EP1 Receptor
9%
Isometric Tension
9%
G Protein-coupled Receptor
9%
EP4 Receptor
9%
NF449
9%
EP3 Receptor
9%
Pharmacology, Toxicology and Pharmaceutical Science
14,15 Epoxy 5,8,11 Icosatrienoic Acid
100%
Prostaglandin E Receptor 2
100%
Receptor
36%
Receptor Antagonist
36%
Peroxisome Proliferator Activated Receptor
18%
Epoxyicosatrienoic Acid
18%
6 Isopropoxy 9 Oxo 2 Xanthenecarboxylic Acid
18%
Peroxisome Proliferator Activated Receptor Antagonist
18%
Stimulatory Guanine Nucleotide Binding Protein
18%
Prostanoid Receptor
18%
Receptor Agonist
9%
Small Interfering RNA
9%
Indometacin
9%
Kt 5720
9%
N [(5 Bromo 2 Methoxyphenyl)sulfonyl] 3 [2 (2 Naphthylmethyl)phenyl]acrylamide
9%
Prostaglandin Synthase Inhibitor
9%
2 Chloro 5 Nitrobenzanilide
9%
Protein Inhibitor
9%
L 663536
9%
Prostaglandin E2
9%
G Protein Coupled Receptor
9%